Document is current
Any future updates will be listed below
-
Authors
Guglielmelli, Paola https://orcid.org/0000-0003-1809-284X
Loscocco, Giuseppe G. https://orcid.org/0000-0002-6241-1206
Mannarelli, Carmela
Rossi, Elena
Mannelli, Francesco https://orcid.org/0000-0003-4810-6501
Ramundo, Francesco
Coltro, Giacomo
Betti, Silvia
Maccari, Chiara
Ceglie, Sara
Chiusolo, Patrizia https://orcid.org/0000-0002-1355-1587
Paoli, Chiara
Barbui, Tiziano https://orcid.org/0000-0003-2747-6327
Tefferi, Ayalew https://orcid.org/0000-0003-4605-3821
De Stefano, Valerio https://orcid.org/0000-0002-5178-5827
Vannucchi, Alessandro M. https://orcid.org/0000-0001-5755-0730
- License Information
-
More Information
Article History
Received: 19 October 2021
Accepted: 12 November 2021
First Online: 11 December 2021
Competing interests
: PG received personal fees for advisory board and/or lectures from Novartis. VDS received personal fees for advisory board and/or lectures from AbbVie, AOP Orphan Pharmaceutical, and Novartis, and research grants from AbbVie and Novartis. AMV received personal fees for advisory board and/or lectures from Novartis, AbbVie, AOP Pharmaceuticals, BMS and Incyte. All other authors have no conflict to report.
